share_log

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

8-K:Biote公布2024年第三季度财务业绩持续盈利增长纵向整合推动毛利率提高推出专有临床决策支持软件以增强竞争优势
美股SEC公告 ·  11/12 16:26
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息